Status:
RECRUITING
MAPS PrEP Van Study
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
HIV Infection
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
For this study the investigators aim to see if giving participants an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually act...
Detailed Description
The purpose of this study is to evaluate a pilot program that provides Pre-Exposure Prophylaxis (PrEP) for people who use drugs (PWUD) and are at risk for contracting HIV. Given the ongoing overdose c...
Eligibility Criteria
Inclusion
- 18 years or older, active drug injection user and/or sexually active, referred from the Syringe Service Program
Exclusion
- positive HIV status
Key Trial Info
Start Date :
September 17 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06908252
Start Date
September 17 2025
End Date
December 31 2025
Last Update
September 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke Department of Population Health Sciences
Durham, North Carolina, United States, 27701